Dr. Perez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
262 Danny Thomas Pl
Memphis, TN 38105Phone+1 888-226-4343Fax+1 901-595-3842
Education & Training
- Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2010 - 2014
- Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2009 - 2010
- Vanderbilt University School of MedicineClass of 2009
- Vanderbilt UniversityPh.D., Biochemistry, 2002 - 2006
- University of Puerto RicoB.S., Industrial Microbiology, Magna Cum Laude, 1996 - 2000
Certifications & Licensure
- TN State Medical License 2023 - 2026
- NY State Medical License 2010 - 2024
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- 1ST place winner, Resident Poster Viewing Recognition Award in the Biology Category ASTRO, 2013
- John G. Coniglio Prize in Biochemistry Vanderbilt University School of Medicine, 2009
- Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship, Public Health Service Department of Health and Human Services, 2007
- Join now to see all
Clinical Trials
- Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 56 citationsFavorable prognosis in patients with T1a/T1bN0 triple‐negative breast cancers treated with multimodality therapyAlice Y. Ho, Gaorav P. Gupta, Tari A. King, C.A. Perez, Sujata Patil
Cancer. 2012-10-15 - 66 citationsIGFBP-3 Is a Direct Target of Transcriptional Regulation by ΔNp63α in Squamous EpitheliumChristopher E. Barbieri, Carmen A. Perez, Kimberly N. Johnson, Kim Ely, Dean Billheimer
Cancer Research. 2005-03-15 - 10 citationsNo evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomesJerry J. Jaboin, Misun Hwang, Carmen A. Perez, Calvin Cooper, Heidi Chen
Urologic Oncology. 2011-05-01
Journal Articles
- Black Race as a Prognostic Factor in Triple-Negative Breast Cancer Patients Treated with Breast-Conserving Therapy: A Large, Single-Institution Retrospective AnalysisPerez C.A., Zumsteg Z.S., Gupta G., Morrow M., Arnold B., Patil S.M., Traina T.A., Robson M.E., Wen Y.H., McCormick B., Powell S., and Ho A.Y., Breast Cancer Res Treat, 1/1/2013
- Favorable Prognosis in Patients with T1a/bN0 Triple Negative Breast Cancers Treated with Multimodality TherapyHo A.Y., Gupta G., King T.A., Perez C.A., Patil S.M., Rogers K.H., Wen Y.H., Brogi E., Morrow M., Hudis C.A., Traina T., McCormick B., Powell S.N., and Robson M.E., Cancer, 1/1/2012
- Interactive Semi-Automatic Contour Delineation Using Statistical Conditional Random Fields FrameworkHu Y.C., Grossberg M.D., Wu A., Riaz N., Perez C.A., and Mageras G.S., Medical Physics, 1/1/2012
- Join now to see all
Abstracts/Posters
- Prognostic Value of Pre and Post-Radiotherapy [18F]FDG-PET/CT Metrics in Limited–Stage Small Cell Lung Cancer.Ong L., Perez C.A., Foster A., Pietanza M.C., Rosenzweig K., Gelblum D.Y., Dunphy M.P., Rimner A., Wu A.J., ASTRO 55th Annual Meeting, Atlanta, GA, 9/22/2013
- Acute Innate Immune Response Profiles Following Cranial Irradiation.Perez C.A., Masheeb Z., Smith O.M., D’Agostino P., Haimovitz-Friedman A., Bulloch K., van den Brink M.R.M., ASTRO 55th Annual Meeting, Atlanta, GA, 9/22/2013
- Interleukin-7 as a Candidate Agent for Mitigating Radiation-Induced Hematologic Injury.Perez C.A., Velardi E., Haimovitz-Friedman A., van den Brink M., ASTRO 55th Annual Meeting, Atlanta, GA, 9/22/2013
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: